Borrowings (Tables)
|
3 Months Ended |
Mar. 31, 2025 |
Debt Instrument [Line Items] |
|
Summary of Carrying Value of Convertible Notes |
The components of the carrying value of the September 2029 Notes were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
|
December 31, 2024 |
|
Principal amount of debt |
$ |
|
118,390 |
|
|
|
$ |
|
115,000 |
|
Unamortized deferred financing cost |
|
|
(3,417 |
) |
|
|
|
|
(3,433 |
) |
Issuance premium and/or (discount), net of accretion |
|
|
30 |
|
|
|
|
|
— |
|
Carrying value of September 2029 Notes |
$ |
|
115,003 |
|
|
|
$ |
|
111,567 |
|
|
Schedule of Outstanding Unsecured Notes |
As of March 31, 2025 and December 31, 2024, the Company had the following outstanding Unsecured Notes (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
|
December 31, 2024 |
|
Series A Notes, net of $1,529 and $1650, respectively, of unamortized deferred financing costs |
|
$ |
|
140,971 |
|
|
|
$ |
|
140,850 |
|
August 2026 Notes, net of $805 and $950, respectively, of unamortized deferred financing costs |
|
|
|
124,195 |
|
|
|
|
|
124,050 |
|
September 2029 Notes, net of $3,387 and $3433, respectively, of unamortized deferred financing costs |
|
|
|
115,003 |
|
|
|
|
|
111,567 |
|
March 2029 Notes, net of $2,840 and $2879, respectively, of unamortized deferred financing costs |
|
|
|
112,421 |
|
|
|
|
|
112,121 |
|
December 2026 Notes, net of $636 and $729, respectively, of unamortized deferred financing costs |
|
|
|
74,364 |
|
|
|
|
|
74,271 |
|
2025 Notes, net of $0 and $81, respectively, of unamortized deferred financing costs |
|
|
|
— |
|
|
|
|
|
152,419 |
|
Convertible Notes, net of $0 and $605, respectively, of unamortized deferred financing costs and discount |
|
|
|
— |
|
|
|
|
|
49,395 |
|
Total Unsecured Notes, net of $9,197 and $10,327, respectively, of unamortized deferred financing costs |
|
$ |
|
566,954 |
|
|
|
$ |
|
764,673 |
|
|
Series A Notes |
|
Debt Instrument [Line Items] |
|
Components of Interest Expense and Related Fees |
The components of interest expense and related fees for the Series A Notes are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2025 |
|
|
|
|
March 31, 2024 |
|
|
Stated interest expense |
$ |
|
2,701 |
|
|
|
$ |
|
— |
|
|
Amortization of deferred financing costs |
|
|
120 |
|
|
|
|
|
— |
|
|
Total interest and amortization of deferred financing costs |
$ |
|
2,821 |
|
|
|
$ |
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average effective interest rate |
|
|
7.9 |
|
% |
|
|
|
— |
|
% |
Weighted average outstanding balance |
$ |
|
142,500 |
|
|
|
$ |
|
— |
|
|
|
2025 Notes |
|
Debt Instrument [Line Items] |
|
Components of Interest Expense and Related Fees |
The components of interest expense and related fees for the 2025 Notes are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2025 |
|
|
|
|
March 31, 2024 |
|
|
Stated interest expense |
$ |
|
445 |
|
|
|
$ |
|
3,194 |
|
|
Amortization of deferred financing costs |
|
|
81 |
|
|
|
|
|
498 |
|
|
Total interest and amortization of deferred financing costs |
$ |
|
526 |
|
|
|
$ |
|
3,692 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average effective interest rate |
|
|
8.3 |
|
% |
|
|
|
8.1 |
|
% |
Weighted average outstanding balance |
$ |
|
25,417 |
|
|
|
$ |
|
182,500 |
|
|
|
6.00% Convertible Notes due 2025 |
|
Debt Instrument [Line Items] |
|
Components of Interest Expense and Related Fees |
The components of interest expense and related fees for the Convertible Notes were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2025 |
|
|
|
|
March 31, 2024 |
|
|
Stated interest expense |
$ |
|
417 |
|
|
|
$ |
|
750 |
|
|
Amortization of deferred financing costs and original issue discount |
|
|
89 |
|
|
|
|
|
166 |
|
|
Total interest and amortization of deferred financing costs and original issue discount |
$ |
|
506 |
|
|
|
$ |
|
916 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average effective interest rate |
|
|
7.1 |
|
% |
|
|
|
7.3 |
|
% |
Weighted average outstanding balance |
$ |
|
28,333 |
|
|
|
$ |
|
50,000 |
|
|
|
Summary of Carrying Value of Convertible Notes |
The components of the carrying value of the Convertible Notes were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
|
December 31, 2024 |
|
Principal amount of debt |
$ |
|
— |
|
|
|
$ |
|
50,000 |
|
Unamortized debt financing cost |
|
|
— |
|
|
|
|
|
(356 |
) |
Original issue discount, net of accretion |
|
|
— |
|
|
|
|
|
(249 |
) |
Carrying value of Convertible Notes |
$ |
|
— |
|
|
|
$ |
|
49,395 |
|
|
August 2026 Notes |
|
Debt Instrument [Line Items] |
|
Components of Interest Expense and Related Fees |
The components of interest expense and related fees for the 2026 Notes are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2025 |
|
|
|
|
March 31, 2024 |
|
|
Stated interest expense |
$ |
|
1,367 |
|
|
|
$ |
|
1,367 |
|
|
Amortization of deferred financing costs |
|
|
144 |
|
|
|
|
|
144 |
|
|
Total interest and amortization of deferred financing costs |
$ |
|
1,511 |
|
|
|
$ |
|
1,511 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average effective interest rate |
|
|
4.8 |
|
% |
|
|
|
4.8 |
|
% |
Weighted average outstanding balance |
$ |
|
125,000 |
|
|
|
$ |
|
125,000 |
|
|
|
December 2026 Notes |
|
Debt Instrument [Line Items] |
|
Components of Interest Expense and Related Fees |
The components of interest expense and related fees for the December 2026 Notes are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2025 |
|
|
|
|
March 31, 2024 |
|
|
Stated interest expense |
$ |
|
797 |
|
|
|
$ |
|
797 |
|
|
Amortization of deferred financing costs |
|
|
93 |
|
|
|
|
|
99 |
|
|
Total interest and amortization of deferred financing costs |
$ |
|
890 |
|
|
|
$ |
|
896 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average effective interest rate |
|
|
4.7 |
|
% |
|
|
|
4.8 |
|
% |
Weighted average outstanding balance |
$ |
|
75,000 |
|
|
|
$ |
|
75,000 |
|
|
|
March 2029 Notes |
|
Debt Instrument [Line Items] |
|
Components of Interest Expense and Related Fees |
The components of interest expense and related fees for the March 2029 Notes are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2025 |
|
|
|
|
March 31, 2024 |
|
|
Stated interest expense |
$ |
|
2,264 |
|
|
|
$ |
|
75 |
|
|
Amortization of deferred financing costs |
|
|
173 |
|
|
|
|
|
5 |
|
|
Total interest and amortization of deferred financing costs |
$ |
|
2,437 |
|
|
|
$ |
|
80 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average effective interest rate |
|
|
8.5 |
|
% |
|
|
|
8.5 |
|
% |
Weighted average outstanding balance |
$ |
|
115,023 |
|
|
|
$ |
|
3,791 |
|
|
|
Summary of Carrying Value of Convertible Notes |
The components of the carrying value of the March 2029 Notes were as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2025 |
|
|
|
December 31, 2024 |
|
Principal amount of debt |
$ |
|
115,261 |
|
|
|
$ |
|
115,000 |
|
Unamortized deferred financing cost |
|
|
(2,842 |
) |
|
|
|
|
(2,879 |
) |
Issuance premium and/or (discount), net of accretion |
|
|
2 |
|
|
|
|
|
— |
|
Carrying value of March 2029 Notes |
$ |
|
112,421 |
|
|
|
$ |
|
112,121 |
|
|
September 2029 Notes |
|
Debt Instrument [Line Items] |
|
Components of Interest Expense and Related Fees |
The components of interest expense and related fees for the September 2029 Notes are as follows (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2025 |
|
|
|
|
March 31, 2024 |
|
|
Stated interest expense |
$ |
|
2,265 |
|
|
|
$ |
|
— |
|
|
Amortization of deferred financing costs |
|
|
184 |
|
|
|
|
|
— |
|
|
Total interest and amortization of deferred financing costs |
$ |
|
2,449 |
|
|
|
$ |
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average effective interest rate |
|
|
8.5 |
|
% |
|
|
|
— |
|
% |
Weighted average outstanding balance |
$ |
|
115,251 |
|
|
|
$ |
|
— |
|
|
|
KeyBank Credit Facility |
|
Debt Instrument [Line Items] |
|
Components of Interest Expense and Related Fees |
The summary information regarding the KeyBank Credit Facility is as follows (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
|
Three Months Ended |
|
|
|
|
March 31, 2025 |
|
|
|
|
March 31, 2024 |
|
|
Stated interest expense |
$ |
|
6,131 |
|
|
|
$ |
|
4,843 |
|
|
Amortization of deferred financing costs |
|
|
385 |
|
|
|
|
|
206 |
|
|
Total interest and amortization of deferred financing costs |
$ |
|
6,516 |
|
|
|
$ |
|
5,049 |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average effective interest rate |
|
|
8.5 |
|
% |
|
|
|
9.1 |
|
% |
Weighted average outstanding balance |
$ |
|
305,296 |
|
|
|
$ |
|
221,086 |
|
|
|